The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Interventions for valvular disease and heart failure

Interatrial shunting for heart failure: current evidence and future perspectives

EuroIntervention 2019;15:164-171. DOI: 10.4244/EIJ-D-18-01211

1. Department of Cardiology, Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada; 2. Heart Failure and Transplantation Program, Vanderbilt University Medical Center, Nashville, TN, USA; 3. Departamento de Investigación Clínica, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico; 4. Germans Trias i Pujol University Hospital, Badalona, Spain; 5. Department of Pulmonology, Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada

The creation of an interatrial shunt in order to decompress the right or left atrium in patients with right and left ventricular failure, respectively, has been used as an alternative therapy to improve symptoms and clinical outcomes in patients with pulmonary hypertension-right heart failure and left heart failure refractory to optimal medical therapy. If ongoing randomised clinical trials further substantiate these beneficial effects in patients with chronic HF, interatrial shunting will represent an important new approach for treating this population.

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Characterisation of lesions undergoing ischaemia-driven revascularisation after complete revascularisation versus culprit lesion only in patients with STEMI and multivessel disease: a DANAMI-3-PRIMULTI substudy